Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News MannKind Corp MNKD

Healthcare Biotechnology
MannKind Corporation is a biopharmaceutical company. It is focused on the development and commercialization of inhaled therapeutic products for patients with endocrine and orphan lung diseases. Its technologies include Technosphere dry-powder formulations and Dreamboat inhalation devices, which offers delivery of medicines to the deep lung where they can exert an effect locally or enter the... see more

Recent & Breaking News (NDAQ:MNKD)

NASDAQ Stocks On The Move: (NASDAQ: MNKD), (NASDAQ: HIMX)

Accesswire April 10, 2013

Free Research Reports on APOL, IVR, MNKD and QCOR Issued by the Bedford Report

Marketwired April 10, 2013

Free Research Reports on FNMA, HES, MNKD and VOD Issued by the Bedford Report

Marketwired April 4, 2013

Before the Bell Scans of MannKind, Ariad Pharma, ZIOPHARM Oncology, NPS Pharma, and Santarus

PR Newswire March 22, 2013

Key to Success, How to Profit: ECL, SSYS, MNKD and PAY

Marketwired March 15, 2013

The Real Story Behind MLNX, BCS, ASML and MNKD

Marketwired March 13, 2013

Free Research Reports on HFC, LPR, MERU and MNKD Issued by the Bedford Report

Marketwired March 12, 2013

Drug Approvals, Increased R&D and Strong Product Portfolios Driving New Growth - Research Report on Medivation, MannKind, Questcor Pharmaceuticals, Charles River Laboratories and Peregrine Pharmaceuticals

PR Newswire March 12, 2013

MannKind and H&R Block Report: (NASDAQ: MNKD), (NYSE: HRB)

Accesswire March 11, 2013

MannKind and Opko Health Announcements: (NASDAQ: MNKD), (NYSE: OPK)

Accesswire March 2, 2013

MannKind Corporation to Present at the Cowen and Company 33rd Annual Health Care Conference

Business Wire February 26, 2013

MannKind and Ariad Pharma Under Review: Biotech Companies Receive Drug Approvals

PR Newswire February 22, 2013

Free Research Reports on ARNA, DSCO, MNKD and ZIOP Issued by the Bedford Report

Marketwired February 19, 2013

MannKind Corporation Reports 2012 Fourth Quarter and Full Year Financial Results

Business Wire February 11, 2013

Sharp Increase in FDA Drug Approvals a Major Factor in Biotech Industry's Success

Marketwired February 6, 2013

MannKind Corporation to Hold 2012 Fourth Quarter and Full Year Financial Results Conference Call on February 11, 2013

Business Wire February 4, 2013

Should Recent Insider Buying on AA, DVA, DNR and MNKD Matter to You?

Marketwired January 15, 2013

Major Revenue Losses From Patent Expirations Forces Big Pharma Companies to Look to the Biotech Industry for Replacements

Marketwired January 10, 2013

MannKind Corporation to Present at The 31st Annual J.P. Morgan Healthcare Conference

Business Wire January 3, 2013

Should Recent Insider Buying on MNKD, TCB, UTHR Matter to You?

Marketwired December 26, 2012